骨整合植入市场－全球产业规模、份额、趋势、机会及预测（依产品、材料、最终用途、地区及竞争格局划分，2021-2031年）

全球骨整合植入市场预计将从 2025 年的 90.3 亿美元成长到 2031 年的 143.6 亿美元，复合年增长率为 8.04%。

这些植入被定义为一种假体装置，它能在天然骨骼和承重假体固定装置之间建立直接的结构和功能连接，而无需中间软组织填充。推动这一市场成长的关键因素包括全球人口快速老化以及骨关节炎和无牙症等慢性骨病发病率的上升，这些疾病需要长期重组手术。澳洲整形外科协会国家关节重建登记处的一份报告也印证了这种日益增长的临床需求，该报告指出，到2024年，预计将进行约213万例髋关节、膝关节和肩关节关节重建手术，凸显了对骨整合解决方案的巨大需求。

然而，这些先进技术也带来了潜在的生物学併发症和高成本等重大挑战。诸如植体周围植入和骨组织与植入材料整合失败等临床问题，可能导致昂贵的修復手术和患者不满。这些风险要求严格的监管合规和长期的密切监测，这可能会阻碍新技术进入市场，并减缓其市场普及速度。

市场驱动因素

患者对美观牙齿修復和美容牙科治疗的需求激增，成为市场扩张的主要催化剂，这主要源于他们对自然美观、持久耐用的牙齿缺失解决方案的日益重视。与活动植入相比，骨整合植入的临床优势进一步强化了这一趋势，植体具有更高的稳定性，并有助于保护颚骨结构。领先的製造商正经历着显着的市场成长。例如，士卓曼集团在其2024年2月发布的2023年度报告中指出，其年销售额达到24亿瑞士法郎，这主要得益于其植入业务两位数的销售成长。同样，ZimVie公司在2024年2月发布的2023年第四季及全年财务报告中也强调，其第三方牙科净销售额达到4.572亿美元。

此外，骨锚式义肢卓越的功能性活动能力和生活品质是其备受青睐的关键因素，尤其对于肢体缺失或遭受创伤的患者更是如此。与可能导致皮肤问题和限制活动的传统套筒式义肢不同，骨整合系统直接固定在骨骼上，提供出色的本体感觉和可靠的机械控制。这项技术变革正推动截肢患者群体迅速接受此类义肢，Integrum AB 于 2024 年 5 月发布的《2023/24 财年财务报告》印证了这一点。该公司报告净销售额为 1.041 亿瑞典克朗，较上年度增长 40.2%，反映出骨锚式活动解决方案在全球范围内的日益普及。

市场挑战

由于生物风险和不断上涨的手术成本的双重压力，骨整合植入市场面临巨大的成长障碍。由于其固有的临床失败风险，例如植体周围植入和骨不连，监管机构对新参与企业制定了严格的监管要求。这些要求增加了先进修復解决方案商业化所需的时间和资金，从而有效地减缓了创新步伐。此外，这些器械的高昂费用也限制了其普及，因为医疗系统和保险公司会仔细审查一旦植入失败，高昂的翻修手术费用是否具有长期的经济永续性。

大量患者需要持续监测，这加剧了营运方面的挑战，对医疗资源造成了巨大压力。正如英国国家关节登记处2025年年度报告所述，仅在2024年，就报告了263,865例髋关节、膝关节、肩关节、肘关节和关节重建关节重建。如此高的手术量凸显了强制性长期追踪和监管合规所带来的巨大后勤和经济负担。因此，製造商被迫将大量资源投入上市后监测，而非研发，这直接阻碍了下一代骨整合技术的快速引入和广泛应用。

市场趋势

机器人和导航手术系统的应用正在从根本上改变临床工作流程，显着提升器械放置的精确度。这些技术利用即时触觉回馈和术前数位化规划，确保最佳定位，这对于最大限度地减少组织损伤和提高复杂整形外科和牙科手术的初始稳定性至关重要。随着临床医生寻求减少人为误差并提高手术一致性，这些自动化平台的应用正在加速。产业数据也印证了这一趋势，例如Neocis公司于2024年1月发布的题为「牙科机器人领导者获得2000万美元资金筹措」的新闻稿，该新闻稿指出，该公司已使用其机器人平台植入超过4万颗植入，凸显了自动化手术执行的日益普及。

同时，将3D列印技术应用于患者特异性植入正在重新定义重组标准，使得生产传统製造技术无法复製的复杂解剖形状成为可能。积层製造技术有助于建构高度多孔的钛晶格，模拟鬆质骨结构，从而促进更深层的生物固定，并加速严重解剖缺陷患者的骨融合过程。这种向客製化解决方案的转变正在为产业创造巨大的经济价值。根据Materials公司于2024年2月发布的“2023年第四季及全年财务业绩”，医疗部门营收年增19.5%至1.01376亿欧元，反映出市场对客製化骨整合技术的需求日益增长。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球骨整合植入市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 副产品（人工植牙、髋植入、膝关节移植、脊椎移植、其他）
  • 依材质（陶瓷植入、氧化锆植入、不銹钢植入、钛植入体、金属植入、其他）
  • 按用途（医院、门诊机构）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美骨整合植入市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲骨整合植入市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区骨整合植入市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲骨整合植入市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美骨整合植入市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球骨整合植入市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Zimmer Biomet
• Straumann
• Nobel Biocare
• Dentsply Sirona
• Stryker
• Integrum
• Osstem
• MIS Implants
• Biomet
• Corin

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Osseointegration Implants Market is projected to expand from USD 9.03 Billion in 2025 to USD 14.36 Billion by 2031, registering a CAGR of 8.04%. These implants are defined as prosthetic devices that create a direct structural and functional connection between living bone and a load-bearing artificial fixture, bypassing the need for intervening soft tissue. The primary drivers fueling this market growth include a rapidly aging global population and the rising incidence of chronic bone disorders, such as osteoarthritis and edentulism, which require long-term reconstructive surgeries. This increasing clinical necessity is highlighted by the Australian Orthopaedic Association National Joint Replacement Registry, which reported a cumulative total of approximately 2.13 million hip, knee, and shoulder replacement procedures in 2024, emphasizing the substantial demand for osseointegrated solutions.

However, the industry faces significant hurdles regarding potential biological complications and the high costs inherent to these advanced procedures. Clinical issues such as peri-implantitis or the failure of the bone to properly fuse with the implant material can result in expensive revisions and patient dissatisfaction. These risks necessitate strict regulatory compliance and rigorous long-term monitoring, which can create barriers to entry for new technologies and slow the rate of widespread market adoption.

Market Driver

The surging demand for aesthetic dental restorations and cosmetic dentistry acts as a major catalyst for market expansion, as patients increasingly prioritize visually natural, long-term solutions for tooth loss. This trend is reinforced by the clinical superiority of osseointegrated implants over removable dentures, which offer enhanced stability and help preserve jawbone structure. Leading manufacturers are observing significant uptake in adoption; for instance, Straumann Group reported full-year revenue of CHF 2.4 billion in its 'Annual Report 2023' released in February 2024, driven by double-digit volume growth in its implantology business. Similarly, ZimVie Inc.'s 'Fourth Quarter and Full Year 2023 Financial Results' from February 2024 highlighted third-party net sales of $457.2 million specifically from its dental segment.

Additionally, the superior functional mobility and quality of life provided by bone-anchored prosthetics serve as a critical driver, particularly for patients dealing with limb loss and trauma. Unlike conventional socket prostheses that can cause skin complications and restrict movement, osseointegrated systems attach directly to the skeleton to enable improved proprioception and reliable mechanical control. This technological shift is fostering rapid acceptance among amputee populations, as evidenced by Integrum AB's 'Year-End Report 2023/24' in May 2024. The company reported net sales of 104.1 million SEK, a 40.2% increase over the previous fiscal year, reflecting the expanding global utilization of these bone-anchored mobility solutions.

Market Challenge

The osseointegration implants market faces a substantial impediment to growth stemming from the combined pressures of biological risks and elevated procedural costs. The inherent potential for clinical failures, such as peri-implantitis or incomplete bone fusion, compels regulatory bodies to mandate stringent surveillance requirements for new market entrants. These obligations increase the time and capital needed to bring advanced prosthetic solutions to commercialization, effectively stalling the pace of innovation. Furthermore, the financial burden of these devices limits accessibility, as healthcare systems and insurers scrutinize the long-term economic viability of funding expensive revisions in cases of implant failure.

This operational challenge is exacerbated by the immense volume of patients requiring continuous monitoring, which places a heavy strain on healthcare resources. As noted in the National Joint Registry's 2025 Annual Report, 263,865 hip, knee, shoulder, elbow, and ankle replacement procedures were submitted during the 2024 calendar year alone. Such a high procedural volume underscores the massive logistical and financial liability associated with mandatory long-term follow-up and regulatory compliance. Consequently, manufacturers must divert significant resources toward post-market surveillance rather than research and development, directly hampering the sector's ability to rapidly introduce and scale next-generation osseointegrated technologies.

Market Trends

The implementation of robotic-assisted and navigational surgical systems is fundamentally altering clinical workflows by enhancing the precision of fixture placement. These technologies utilize real-time haptic guidance and pre-operative digital planning to ensure optimal positioning, which is critical for minimizing tissue trauma and maximizing initial stability in complex orthopedic and dental procedures. The adoption of such automated platforms is accelerating as clinicians seek to reduce human error and improve operative consistency. This uptake is substantiated by industry data; in January 2024, Neocis reported in the press release 'Dental robotics leader Neocis secures $20M in funding' that a cumulative total of more than 40,000 implants have been placed using its robotic-assisted platform, highlighting the growing reliance on automated surgical execution.

Concurrently, the integration of three-dimensional printing for patient-specific implants is redefining reconstruction standards by enabling the fabrication of complex, anatomically matched geometries that traditional manufacturing cannot reproduce. Additive manufacturing facilitates the creation of highly porous titanium lattices that mimic trabecular bone structure, thereby promoting deeper biological fixation and accelerating the fusion process for patients with severe anatomical defects. This shift toward customized solutions is generating substantial economic value within the sector; according to Materialise's 'Fourth Quarter and Full Year 2023 Results' in February 2024, revenue from its Medical segment grew by 19.5% year-over-year to 101,376 kEUR, reflecting the surging demand for tailored osseointegration technologies.

Key Market Players

• Zimmer Biomet
• Straumann
• Nobel Biocare
• Dentsply Sirona
• Stryker
• Integrum
• Osstem
• MIS Implants
• Biomet
• Corin

Report Scope

In this report, the Global Osseointegration Implants Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Osseointegration Implants Market, By Product

• Dental Implants
• Hip Implants
• Knee Implants
• Spinal Implants
• Others

Osseointegration Implants Market, By Material

• Ceramic Implants
• Zirconia Implants
• Stainless Steel Implants
• Titanium Implants
• Metallic Implants
• Others

Osseointegration Implants Market, By End Use

• Hospitals
• Outpatient Facilities

Osseointegration Implants Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Osseointegration Implants Market.

Available Customizations:

Global Osseointegration Implants Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Osseointegration Implants Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Dental Implants, Hip Implants, Knee Implants, Spinal Implants, Others)
  • 5.2.2. By Material (Ceramic Implants, Zirconia Implants, Stainless Steel Implants, Titanium Implants, Metallic Implants, Others)
  • 5.2.3. By End Use (Hospitals, Outpatient Facilities)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Osseointegration Implants Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Material
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Osseointegration Implants Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Material
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Osseointegration Implants Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Material
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Osseointegration Implants Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Material
      • 6.3.3.2.3. By End Use

7. Europe Osseointegration Implants Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Material
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Osseointegration Implants Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Material
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Osseointegration Implants Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Material
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Osseointegration Implants Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Material
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Osseointegration Implants Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Material
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Osseointegration Implants Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Material
      • 7.3.5.2.3. By End Use

8. Asia Pacific Osseointegration Implants Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Material
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Osseointegration Implants Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Material
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Osseointegration Implants Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Material
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Osseointegration Implants Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Material
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Osseointegration Implants Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Material
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Osseointegration Implants Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Material
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Osseointegration Implants Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Material
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Osseointegration Implants Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Material
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Osseointegration Implants Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Material
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Osseointegration Implants Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Material
      • 9.3.3.2.3. By End Use

10. South America Osseointegration Implants Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Material
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Osseointegration Implants Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Material
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Osseointegration Implants Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Material
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Osseointegration Implants Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Material
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Osseointegration Implants Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Zimmer Biomet
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Straumann
• 15.3. Nobel Biocare
• 15.4. Dentsply Sirona
• 15.5. Stryker
• 15.6. Integrum
• 15.7. Osstem
• 15.8. MIS Implants
• 15.9. Biomet
• 15.10. Corin

16. Strategic Recommendations

17. About Us & Disclaimer